awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38793428-3803DFA6-DAD7-490E-9590-EEB503D4D5A1
Q38793428-3803DFA6-DAD7-490E-9590-EEB503D4D5A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38793428-3803DFA6-DAD7-490E-9590-EEB503D4D5A1
From IgE to Omalizumab.
P2860
Q38793428-3803DFA6-DAD7-490E-9590-EEB503D4D5A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38793428-3803DFA6-DAD7-490E-9590-EEB503D4D5A1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
18648e1859e1a0be63c553331a503afa6962369e
P2860
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.